Four new drugs get positive EMEA opinions

The European Medicines Agency is recommending that four new drugs be allowed onto the market in Europe including a new therapy from Sanofi-Aventis for the treatment of atrial fibrillation.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom